Continuous subcutaneous insulin infusion (CSII) pumps

Advances in Experimental Medicine and Biology

Volumn 771, Issue , 2013, Pages 414-419

  Valla, Vasiliki ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; SHORT ACTING INSULIN; ANTIDIABETIC AGENT;

ARTICLE; BLOOD GLUCOSE MONITORING; CANNULA; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; DIABETES MELLITUS; DRUG EFFICACY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROSOMIA; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PEDIATRICS; PREGNANCY DIABETES MELLITUS; PUERPERIUM; QUALITY OF LIFE; RISK FACTOR; TREATMENT DURATION; TREATMENT INDICATION; INSTRUMENTATION; INSULIN INFUSION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS;

MLCS; MLOWN;

EID: 84874519251     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: None     Document Type: Article

References (18)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14):977-986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131):837-853.
3. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011; 378(9786):169-181.
4. Brunton S. Beyond glycemic control: treating the entire type 2 diabetes disorder. Postgrad Med 2009; 121(5):68-81
5. Hanaire H. Lassmann-Vague V. Jeandidier N et al., Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008; 34(4):401-423.
6. Potti LG, Haines ST. Continuous subcutaneous insulin infusion therapy: a primer on insulin pumps. J Arm Pharm Assoc (2003) 2009; 49(1): 1-13.
7. Morviducci L, Di Flaviani A, Lauria A et al. Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit. Diabetes Technol Ther 2011; Epub ahead of press.
8. Conwell LS, Pope E, Artiles AM et al. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr 2008; 152(5):622-628.
9. Reznik Y. Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes. Diabetes Metab 2010; 36(6 Pt 1):415-421.
10. Valla V. Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. Exp Diabetes Res 2010: ID178372, Epub.
11. Cummins E, Royle P, Snaith A et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 2010; 14(11):1-181.
12. Monami M, Lamanna C, Marchionni N et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol 2010; 47(Suppl 1):77-81.
13. Monami M, Lamanna C, Marchionni N et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. Exp Clin Endocrinol Diabetes 2009; 117(5):220-222.
14. Jeitler K, Horvath K, Berghold A et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008; 51(6):941-951.
15. Pańkowska E, Błazik M, Dziechciarz P et al. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009; 10(1):52-58.
16. Rubin RR, Peyrot M. Patient-reported outcomes and diabetes technology: a systematic review of the literature. Pediatr Endocrinol Rev 2010; 7(3):405-412.
17. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta analysis of multiple daily insulin injections compared with cutinuous subcutinuous insulin infusion. Diabet Med 2008;25:765-774.
18. Mukhopadhyay A, Farrell T, Fraser RB et al. Continuous subcutaneous insulin infusion vs. intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007; 197(5):447-456.